Paloma Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,775,000
| Closed | -$1.36M | – | 534 |
|
|
2023
Q1 | $1.36M | Buy |
+3,775,000
| New | +$1.36M | 0.05% | 54 |
|
|
2022
Q2 | – | Sell |
-47,591
| Closed | -$111K | – | 1481 |
|
|
2022
Q1 | $111K | Buy |
+47,591
| New | +$111K | ﹤0.01% | 1169 |
|
|
2019
Q2 | – | Sell |
-38,300
| Closed | -$182K | – | 1874 |
|
|
2019
Q1 | $182K | Buy |
38,300
+24,000
| +168% | +$114K | ﹤0.01% | 1208 |
|
|
2018
Q4 | $34K | Buy |
+14,300
| New | +$34K | ﹤0.01% | 934 |
|
|
2017
Q3 | – | Sell |
-93,900
| Closed | -$188K | – | 1837 |
|
|
2017
Q2 | $188K | Buy |
+93,900
| New | +$188K | ﹤0.01% | 1504 |
|